NO20065260L - Tri(cyklo)substituerte amidforbindelser - Google Patents
Tri(cyklo)substituerte amidforbindelserInfo
- Publication number
- NO20065260L NO20065260L NO20065260A NO20065260A NO20065260L NO 20065260 L NO20065260 L NO 20065260L NO 20065260 A NO20065260 A NO 20065260A NO 20065260 A NO20065260 A NO 20065260A NO 20065260 L NO20065260 L NO 20065260L
- Authority
- NO
- Norway
- Prior art keywords
- cyclo
- tri
- amide compounds
- substituted amide
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forbindelser med formel (I): eller farmasøytisk akseptable salter derav, er anvendelige ved profylaktisk og terapeutisk behandling av hyperglykemi og diabetes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56417104P | 2004-04-21 | 2004-04-21 | |
US60107704P | 2004-08-12 | 2004-08-12 | |
PCT/GB2005/050053 WO2005103021A1 (en) | 2004-04-21 | 2005-04-19 | Tri(cyclo) substituted amide compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065260L true NO20065260L (no) | 2006-11-21 |
Family
ID=34965439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065260A NO20065260L (no) | 2004-04-21 | 2006-11-15 | Tri(cyklo)substituerte amidforbindelser |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080242869A1 (no) |
EP (1) | EP1740560A1 (no) |
JP (1) | JP2007533722A (no) |
KR (1) | KR20060134179A (no) |
AU (1) | AU2005235798A1 (no) |
BR (1) | BRPI0510163A (no) |
CA (1) | CA2563192A1 (no) |
EA (1) | EA012204B1 (no) |
IL (1) | IL178473A0 (no) |
MA (1) | MA28545B1 (no) |
MX (1) | MXPA06012008A (no) |
NO (1) | NO20065260L (no) |
NZ (1) | NZ550567A (no) |
WO (1) | WO2005103021A1 (no) |
ZA (1) | ZA200608489B (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050074959A (ko) | 2002-10-03 | 2005-07-19 | 노파르티스 아게 | 제ii형 당뇨병 치료에 유용한 글루코키나아제 활성인자로서의 치환된 (티아졸-2-일)-아미드 또는 술폰아미드 |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
AU2005229416B2 (en) | 2004-04-02 | 2009-03-26 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes |
EP1737870A1 (en) | 2004-04-02 | 2007-01-03 | Novartis AG | Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
WO2006016194A1 (en) * | 2004-08-12 | 2006-02-16 | Prosidion Limited | Substituted phenylacetamides and their use as glucokinase activators |
GB0418058D0 (en) * | 2004-08-12 | 2004-09-15 | Prosidion Ltd | Fluorination process |
CN101272784A (zh) | 2005-09-29 | 2008-09-24 | 塞诺菲-安万特股份有限公司 | 苯基-和吡啶基-1,2,4-噁二唑酮衍生物、它们的制备方法和它们作为药物的用途 |
GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
US20080293741A1 (en) * | 2005-11-03 | 2008-11-27 | Matthew Colin Thor Fyfe | Tricyclo Substituted Amides as Glucokinase Modulators |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
US7910747B2 (en) | 2006-07-06 | 2011-03-22 | Bristol-Myers Squibb Company | Phosphonate and phosphinate pyrazolylamide glucokinase activators |
US7888504B2 (en) | 2006-07-06 | 2011-02-15 | Bristol-Myers Squibb Company | Glucokinase activators and methods of using same |
CA2657566A1 (en) | 2006-07-24 | 2008-01-31 | F. Hoffmann-La Roche Ag | Pyrazoles as glucokinase activators |
US7902248B2 (en) | 2006-12-14 | 2011-03-08 | Hoffmann-La Roche Inc. | Oxime glucokinase activators |
TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
EP2116533B1 (en) * | 2007-03-07 | 2013-07-10 | Kyorin Pharmaceutical Co., Ltd. | Glucokinase activator |
PE20091313A1 (es) * | 2008-01-15 | 2009-09-03 | Lilly Co Eli | (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina |
BRPI0906888A2 (pt) | 2008-01-18 | 2015-11-03 | Astellas Pharma Inc | derivado de fenilacetamida |
US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
PT2275414E (pt) | 2008-04-28 | 2015-09-09 | Teijin Pharma Ltd | Derivado de amida do ácido ciclopentacrílico |
PE20141375A1 (es) | 2008-05-16 | 2014-10-23 | Takeda San Diego Inc | Activadores de glucoquinasa |
EA201100921A1 (ru) * | 2008-12-08 | 2011-12-30 | Эроскрин С.А. | Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ |
UA104742C2 (uk) | 2008-12-19 | 2014-03-11 | Эли Лилли Энд Компани | Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази |
US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
EP2547667A1 (en) | 2010-03-18 | 2013-01-23 | Takeda California, Inc. | Process for the production of 2-amino-5-fluorothiazole |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2226811T3 (es) * | 1999-03-29 | 2005-04-01 | F. Hoffmann-La Roche Ag | Activadores de glucoquinasa. |
US6610846B1 (en) * | 1999-03-29 | 2003-08-26 | Hoffman-La Roche Inc. | Heteroaromatic glucokinase activators |
US6353111B1 (en) * | 1999-12-15 | 2002-03-05 | Hoffmann-La Roche Inc. | Trans olefinic glucokinase activators |
EP1282611B1 (en) * | 2000-05-08 | 2004-10-20 | F. Hoffmann-La Roche Ag | Substituted phenylacetamides and their use as glucokinase activators |
WO2002008209A1 (en) * | 2000-07-20 | 2002-01-31 | F. Hoffmann-La Roche Ag | Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
BR0115999A (pt) * | 2000-12-06 | 2003-09-30 | Hoffmann La Roche | Composto, composição farmacêutica que compreende o mesmo, sua utilização, processo para o tratamento profilático ou terapêutico de diabetes do tipo ii e processo para a preparação do composto |
CN1329386C (zh) * | 2002-04-26 | 2007-08-01 | 霍夫曼-拉罗奇有限公司 | 取代的苯基乙酰胺类及其在制备葡糖激酶激活剂中的应用 |
PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
-
2005
- 2005-04-19 CA CA002563192A patent/CA2563192A1/en not_active Abandoned
- 2005-04-19 BR BRPI0510163-8A patent/BRPI0510163A/pt not_active IP Right Cessation
- 2005-04-19 EP EP05732317A patent/EP1740560A1/en not_active Withdrawn
- 2005-04-19 WO PCT/GB2005/050053 patent/WO2005103021A1/en active Application Filing
- 2005-04-19 JP JP2007508982A patent/JP2007533722A/ja not_active Withdrawn
- 2005-04-19 US US11/578,752 patent/US20080242869A1/en not_active Abandoned
- 2005-04-19 AU AU2005235798A patent/AU2005235798A1/en not_active Abandoned
- 2005-04-19 MX MXPA06012008A patent/MXPA06012008A/es unknown
- 2005-04-19 KR KR1020067022240A patent/KR20060134179A/ko not_active Application Discontinuation
- 2005-04-19 EA EA200601747A patent/EA012204B1/ru not_active IP Right Cessation
- 2005-04-19 NZ NZ550567A patent/NZ550567A/en not_active IP Right Cessation
-
2006
- 2006-10-05 IL IL178473A patent/IL178473A0/en unknown
- 2006-10-11 ZA ZA2006/08489A patent/ZA200608489B/en unknown
- 2006-10-20 MA MA29401A patent/MA28545B1/fr unknown
- 2006-11-15 NO NO20065260A patent/NO20065260L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007533722A (ja) | 2007-11-22 |
IL178473A0 (en) | 2007-02-11 |
EA200601747A1 (ru) | 2007-04-27 |
CA2563192A1 (en) | 2005-11-03 |
ZA200608489B (en) | 2008-06-25 |
EP1740560A1 (en) | 2007-01-10 |
AU2005235798A1 (en) | 2005-11-03 |
MA28545B1 (fr) | 2007-04-03 |
MXPA06012008A (es) | 2007-01-25 |
KR20060134179A (ko) | 2006-12-27 |
EA012204B1 (ru) | 2009-08-28 |
US20080242869A1 (en) | 2008-10-02 |
BRPI0510163A (pt) | 2007-10-02 |
WO2005103021A1 (en) | 2005-11-03 |
NZ550567A (en) | 2010-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065260L (no) | Tri(cyklo)substituerte amidforbindelser | |
NO20053742L (no) | Tri (cyclo)-substituerte amidforbindelser | |
NO20080010L (no) | GPCR-agonister | |
NO20072608L (no) | Biaryloksymetylarenkarboksylsyrer | |
JO2282B1 (en) | Oxazole derivatives | |
NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
NO20055887L (no) | Pyrido'2, 1-A-isokinoliderivater som DPP-IV-inhibitorer | |
NO20082496L (no) | Pyrazinderivater | |
NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
ATE427926T1 (de) | Cycloalkylaminderivate | |
NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
NO20051103L (no) | Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer | |
NO20090064L (no) | Pyrasoler som glucokinase aktivatorer | |
DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
WO2010036613A8 (en) | Novel cyclic benzimidazole derivatives useful anti-diabetic agents | |
IL176648A0 (en) | (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity | |
NO20074872L (no) | Pyrazoler | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
NO20076134L (no) | Benzamidderivater og anvendelser derav | |
NO20072389L (no) | Substituerte benzokinolizinderivater | |
NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
NO20073830L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
WO2004087700A8 (fr) | Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur | |
IL177169A (en) | Use of n-(2-aryl- propionyl)-sulfonamides for the preparation of medicaments for the treatment of spinal cord injury |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |